AMPH

Amphastar Pharmaceuticals (AMPH)

About Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Details

Daily high

$22.64

Daily low

$20.40

Price at open

$22.48

52 Week High

$31.26

52 Week Low

$16.64

Market cap

916.3M

Dividend yield

0.00%

Volume

1.3M

Avg. volume

459,553

P/E ratio

12.18

Amphastar Pharmaceuticals News